Severe edema as an immune-related adverse event following nivolumab therapy: a case report
AME Case Reports · 2026-03 · 10 · 77-77
DOI: 10.21037/acr-2025-298 ↗Kurz gefasst
Fallbericht in der Zeitschrift AME Case Reports, 2026-03. Verfasst von Naoki Miyamoto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health Biosciences, The University of Tokushima, Tokushima, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health Biosciences, The University of Tokushima, Tokushima, Japan.
ORCID-Profile: Naoki Miyamoto
Zitieren
APA
Miyamoto, N., Tsuji, A., Matsui, S., Takehara, E., Takeuchi, T., Fujimoto, K., Morishita, A., Kawakita, N., Toba, H., & Takizawa, H. (2026). Severe edema as an immune-related adverse event following nivolumab therapy: a case report. AME Case Reports, 10, 77-77. https://doi.org/10.21037/acr-2025-298
Vancouver
Miyamoto N, Tsuji A, Matsui S, Takehara E, Takeuchi T, Fujimoto K, et al. Severe edema as an immune-related adverse event following nivolumab therapy: a case report. AME Case Reports. 2026;10:77-77. doi:10.21037/acr-2025-298
BibTeX
@article{Miyamoto2026,
author = {Miyamoto, Naoki and Tsuji, Ayaka and Matsui, Shiori and Takehara, Emi and Takeuchi, Taihei and Fujimoto, Keisuke and Morishita, Atsushi and Kawakita, Naoya and Toba, Hiroaki and Takizawa, Hiromitsu},
title = {Severe edema as an immune-related adverse event following nivolumab therapy: a case report},
journal = {AME Case Reports},
year = {2026},
volume = {10},
pages = {77--77},
doi = {10.21037/acr-2025-298}
}
EUVIMED